<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00289120</url>
  </required_header>
  <id_info>
    <org_study_id>0133-2003</org_study_id>
    <secondary_id>GCRC#2403</secondary_id>
    <nct_id>NCT00289120</nct_id>
  </id_info>
  <brief_title>Effect of Cola on Urinary Stone Risk Factors</brief_title>
  <official_title>Effect of Cola on Urinary Stone Risk Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Examine the effects of cola on risks of kidney stones
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective crossover study examining the risks of cola on stone risk factors.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2003</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Plasma and Urine Parameters</measure>
    <time_frame>at the end of each 6-day intervention in Cola and Water Phase</time_frame>
    <description>The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:
Plasma Parameters:
CA (mg per dL) GLU (mg per dL) BUN (mg per dL) Cr (mg per dL) Prot (mg per dL) ALB (mg per dL)
Urine Parameters:
uCa (mg per dL) uMg (mg per dL) uP (mg per dL) uCr (mg per dL) uCit (mg per dL) uOx (mg per dL) uUA (mg per dL)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Plasma and Urine Parameters</measure>
    <time_frame>at the end of 6-day intervention of Cola and water phase</time_frame>
    <description>The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:
Plasma Parameters:
Na (mEq per L) K (mEq per L) CL (mEq per L) CO2(mEq per L) AG (mEq per L)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Plasma Osmolarity</measure>
    <time_frame>at the end of 6-day intervention of cola and water phase</time_frame>
    <description>The Plasma osmolarity that were assessed at the end of cola and water (arms) phase:
Plasma Parameters:
OSM (mOsm/L)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Plasma and Urine Parameters</measure>
    <time_frame>at the end of 6-day intervention of Cola and water phase</time_frame>
    <description>The Urine Parameters that were assessed at the end of cola and water (arms) phase:
Urine Parameters:
uNa (mEq per d) uK (mEq per d)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Urine Volume</measure>
    <time_frame>at the end of each 6-day intervention in Cola and Water Phase</time_frame>
    <description>The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:
Urine Parameters:
Total Urine Volume (mL/day)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary pH</measure>
    <time_frame>at the end of each 6-day intervention in Cola and Water Phase</time_frame>
    <description>The Urine pH that were assessed at the end of cola and water (arms) phase The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Kidney Stone</condition>
  <arm_group>
    <arm_group_label>Cola beverage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be given 500cc of Cola twice daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deionized water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will be given 500cc of deionized water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cola beverage</intervention_name>
    <description>Subjects will be given 500cc of Cola beverage twice daily to be ingested with breakfast and dinner for six days while on a metabolic diet.There will be a three weeks interval before crossover to the other treatment arm.</description>
    <arm_group_label>Cola beverage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Deionized water</intervention_name>
    <description>Subjects will be given 500cc of deionized water to be ingested twice daily with breakfast and dinner for three weeks while on a metabolic diet. There will be a three weeks interval before crossover to the other treatment arm</description>
    <arm_group_label>Deionized water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  urolithiasis, healthy volunteer

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Ogan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Herrel L, Pattaras J, Solomon T, Ogan K. Urinary stone risk and cola consumption. Urology. 2012 Nov;80(5):990-4. doi: 10.1016/j.urology.2012.07.003. Epub 2012 Sep 25.</citation>
    <PMID>23017784</PMID>
  </results_reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2006</study_first_submitted>
  <study_first_submitted_qc>February 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2006</study_first_posted>
  <results_first_submitted>August 14, 2013</results_first_submitted>
  <results_first_submitted_qc>June 5, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 8, 2014</results_first_posted>
  <last_update_submitted>May 5, 2016</last_update_submitted>
  <last_update_submitted_qc>May 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Kenneth Ogan, MD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>urolithiasis, cola</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Urinary Calculi</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruited patients of Emory University Department of Urology</recruitment_details>
      <pre_assignment_details>Normal subjects and calcium oxalate stone-formers were included.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cola First, Then Water</title>
          <description>Phase 1: Subjects will be given 500cc of Cola beverage twice daily to be ingested with breakfast and dinner for six days while on a metabolic diet.
There will be a three weeks wash-out period before patients entere phase 2 of thre study.
Phase 2: Subjects will be given 500cc of deionized water twice daily to be ingested with breakfast and dinner for six days while on a metabolic diet.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Thirteen subjects, including 10 normal subjects and 3 calcium oxalate stone-formers were enrolled in this prospective cross-over study.</population>
      <group_list>
        <group group_id="B1">
          <title>Cola First, Then Water</title>
          <description>Phase 1: Subjects will be given 500cc of Cola beverage twice daily to be ingested with breakfast and dinner for six days while on a metabolic diet.
There will be a 3-week wash out period before subjects enter phase 2 of the study.
Phase 2: Subjects will be given 500 cc of deionized water beverage twice daily to be ingested with breakfast and dinner for six days while on a metabolic diet.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Study participants</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Normal subjects</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium oxalate stone- formers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Plasma and Urine Parameters</title>
        <description>The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:
Plasma Parameters:
CA (mg per dL) GLU (mg per dL) BUN (mg per dL) Cr (mg per dL) Prot (mg per dL) ALB (mg per dL)
Urine Parameters:
uCa (mg per dL) uMg (mg per dL) uP (mg per dL) uCr (mg per dL) uCit (mg per dL) uOx (mg per dL) uUA (mg per dL)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
        <time_frame>at the end of each 6-day intervention in Cola and Water Phase</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cola</title>
            <description>they ingested 500 mL of cola (regular Publix brand©) twice daily, with breakfast and dinner.</description>
          </group>
          <group group_id="O2">
            <title>Water</title>
            <description>participants ingested 500 mL of deionized water twice daily, with breakfast and dinner.</description>
          </group>
        </group_list>
        <measure>
          <title>The Plasma and Urine Parameters</title>
          <description>The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:
Plasma Parameters:
CA (mg per dL) GLU (mg per dL) BUN (mg per dL) Cr (mg per dL) Prot (mg per dL) ALB (mg per dL)
Urine Parameters:
uCa (mg per dL) uMg (mg per dL) uP (mg per dL) uCr (mg per dL) uCit (mg per dL) uOx (mg per dL) uUA (mg per dL)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
          <units>mg per dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Plasma Proteins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6800" spread="500"/>
                    <measurement group_id="O2" value="6800" spread="500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plasma Albumin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3700" spread="300"/>
                    <measurement group_id="O2" value="3700" spread="300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plasma Calcium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1" spread="0.3"/>
                    <measurement group_id="O2" value="9.0" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean Plasma Glucose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.8" spread="9"/>
                    <measurement group_id="O2" value="95.2" spread="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>blood urea nitrogen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1" spread="4.5"/>
                    <measurement group_id="O2" value="11.1" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plasma Creatinine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.2"/>
                    <measurement group_id="O2" value="2.1" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary Calcium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124.3" spread="74.5"/>
                    <measurement group_id="O2" value="146.4" spread="86.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary Magnesium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.6" spread="43.7"/>
                    <measurement group_id="O2" value="106.8" spread="49.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary Phosphets</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="720.7" spread="224.1"/>
                    <measurement group_id="O2" value="739.6" spread="320.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary Creatinine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1620.1" spread="699.0"/>
                    <measurement group_id="O2" value="1950.1" spread="1057.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary Citrate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="475.9" spread="240.6"/>
                    <measurement group_id="O2" value="727.7" spread="666.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary Oxalates</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.7" spread="25.6"/>
                    <measurement group_id="O2" value="34.7" spread="21.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric acids</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="555.3" spread="183.1"/>
                    <measurement group_id="O2" value="646.4" spread="272.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Plasma and Urine Parameters</title>
        <description>The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:
Plasma Parameters:
Na (mEq per L) K (mEq per L) CL (mEq per L) CO2(mEq per L) AG (mEq per L)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
        <time_frame>at the end of 6-day intervention of Cola and water phase</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Water</title>
            <description>participants ingested 500 mL of deionized water twice daily, with breakfast and dinner.</description>
          </group>
          <group group_id="O2">
            <title>Cola</title>
            <description>they ingested 500 mL of cola (regular Publix brand©) twice daily, with breakfast and dinner.</description>
          </group>
        </group_list>
        <measure>
          <title>The Plasma and Urine Parameters</title>
          <description>The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:
Plasma Parameters:
Na (mEq per L) K (mEq per L) CL (mEq per L) CO2(mEq per L) AG (mEq per L)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
          <units>mEq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Plasma sodium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="138.3" spread="2.5"/>
                    <measurement group_id="O2" value="139.1" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plasma Potassium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="0.2"/>
                    <measurement group_id="O2" value="3.9" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plasma Chlorides</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.8" spread="2.3"/>
                    <measurement group_id="O2" value="105.2" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plasma CO2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.1" spread="2.0"/>
                    <measurement group_id="O2" value="26.4" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Plasma AG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" spread="1.2"/>
                    <measurement group_id="O2" value="7.3" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Plasma Osmolarity</title>
        <description>The Plasma osmolarity that were assessed at the end of cola and water (arms) phase:
Plasma Parameters:
OSM (mOsm/L)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
        <time_frame>at the end of 6-day intervention of cola and water phase</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Water</title>
            <description>participants ingested 500 mL of deionized water twice daily, with breakfast and dinner.</description>
          </group>
          <group group_id="O2">
            <title>Cola</title>
            <description>they ingested 500 mL of cola (regular Publix brand©) twice daily, with breakfast and dinner.</description>
          </group>
        </group_list>
        <measure>
          <title>The Plasma Osmolarity</title>
          <description>The Plasma osmolarity that were assessed at the end of cola and water (arms) phase:
Plasma Parameters:
OSM (mOsm/L)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
          <units>mOsm/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="276.5" spread="4.8"/>
                    <measurement group_id="O2" value="277.5" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Urine Volume</title>
        <description>The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:
Urine Parameters:
Total Urine Volume (mL/day)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
        <time_frame>at the end of each 6-day intervention in Cola and Water Phase</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Water</title>
            <description>participants ingested 500 mL of deionized water twice daily, with breakfast and dinner.</description>
          </group>
          <group group_id="O2">
            <title>Cola</title>
            <description>they ingested 500 mL of cola (regular Publix brand©) twice daily, with breakfast and dinner.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Urine Volume</title>
          <description>The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:
Urine Parameters:
Total Urine Volume (mL/day)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
          <units>mL/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2521.3" spread="1152.6"/>
                    <measurement group_id="O2" value="2266.2" spread="811.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary pH</title>
        <description>The Urine pH that were assessed at the end of cola and water (arms) phase The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
        <time_frame>at the end of each 6-day intervention in Cola and Water Phase</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cola</title>
            <description>they ingested 500 mL of cola (regular Publix brand©) twice daily, with breakfast and dinner.</description>
          </group>
          <group group_id="O2">
            <title>Water</title>
            <description>participants ingested 500 mL of deionized water twice daily, with breakfast and dinner.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary pH</title>
          <description>The Urine pH that were assessed at the end of cola and water (arms) phase The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
          <units>pH</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="0.6"/>
                    <measurement group_id="O2" value="6.0" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Plasma and Urine Parameters</title>
        <description>The Urine Parameters that were assessed at the end of cola and water (arms) phase:
Urine Parameters:
uNa (mEq per d) uK (mEq per d)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
        <time_frame>at the end of 6-day intervention of Cola and water phase</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Water</title>
            <description>participants ingested 500 mL of deionized water twice daily, with breakfast and dinner.</description>
          </group>
          <group group_id="O2">
            <title>Cola</title>
            <description>they ingested 500 mL of cola (regular Publix brand©) twice daily, with breakfast and dinner.</description>
          </group>
        </group_list>
        <measure>
          <title>The Plasma and Urine Parameters</title>
          <description>The Urine Parameters that were assessed at the end of cola and water (arms) phase:
Urine Parameters:
uNa (mEq per d) uK (mEq per d)
The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).
measure of dispersion was standard deviation.</description>
          <units>mEq per d</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Urinary sodium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139.9" spread="40.0"/>
                    <measurement group_id="O2" value="103.9" spread="43.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary Potassium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.3" spread="31.4"/>
                    <measurement group_id="O2" value="41.4" spread="17.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Cola Beverage Phase</title>
          <description>Subjects were given 500cc of Cola twice daily to be ingested with breakfast and dinner for six days while on a metabolic diet.
There will be a three weeks interval (wash out period) before crossover to the other treatment arm.
No adverse event reported.</description>
        </group>
        <group group_id="E2">
          <title>Deionized Water Drinking Phase</title>
          <description>Subjects were given 500cc of regular deionized water twice daily to be ingested with breakfast and dinner for six days while on a metabolic diet.
No adverse event reported.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kenneth Ogan</name_or_title>
      <organization>Emory University</organization>
      <phone>404-778-4898</phone>
      <email>kogan@emory.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

